Orca Bio announced $250 million in aggregate financing in preparation for potential commercialization.
- Amount
- $250M
- Announced
- 9 January 2026
- Lead
- Lightspeed Venture Partners
- Use of funds
- Commercial readiness for Orca-T, East Coast manufacturing capacity, and advancement of clinical pipeline programs.
- Checked
- Amount and date checked against the press source